Alexandra Fux is the fellow of ESR2. She started her scientific career at the Eberhard Karls University of Tübingen where she completed her studies in the field of nanoscience. During her bachelor’s thesis, she worked at the Interfaculty Institute of Biochemistry in the laboratory of Prof. Dr. Michael Duszenko. Her project focused on the inhibition of Cathepsin B as well as the uptake of Fe2O3 nanoparticles in Trypanosoma brucei, the pathogen of the African sleeping sickness. During her master studies, she spent one semester in the Cavendish laboratory in Cambridge in the group of Dr. Sarah Bohndiek, working on pH-sensitive DNA-based nanoprobes as contrast agents in cancer cells. For her master’s thesis, she worked in the Department of Chemical Engineering and Biotechnology at the University of Cambridge in the group of Dr. Ljiljana Fruk where she focused on the functionalization of nanodiamonds to target mitochondria in breast cancer cells.
In January 2020, she started her doctoral training at the Paris Lodron University of Salzburg in the groups of Assoz.-Prof. Dr. Jutta Horejs-Hoeck and Prof. Dr. Albert Duschl. Her work focuses on designing new LPS binding molecules, which can be combined with nanoparticles and be used as a foundation for novel biosensing molecule-based assays. After 15 months of her project, she will be working at Miltenyi Biotec in the group of Dr. Christiane Siewert. Her doctoral program is registered at University of Salzburg (Austria) in the field of Medical Biology to obtain the title of Dr. rer. nat..